Back to products
NAD+ Research Peptide
Adonis NAD+ - Research Peptide (RUO) Price range: £75.99 through £89.99 inc. VAT

Adonis SLU-PP 332 – Research Peptide (RUO)

£89.99 inc. VAT

In stock (can be backordered)

Multi Buy Savings

£89.99
1 piece
£83.69 (7% off)
2 pieces
£80.99 (10% off)
3 - 4 pieces
£76.49 (15% off)
5 - 7 pieces
£71.99 (20% off)
8+ pieces
x
Description

Research Use Only (RUO). Not for human or veterinary use. No medical or therapeutic claims.

SLU-PP-332 – Research Grade

Buy SLU-PP-332 peptide for research — SLU-PP-332 is an experimental PPARδ receptor agonist analogue studied for its potential to enhance fat oxidation, mitochondrial function and endurance. As a next-generation PPARδ modulator, SLU-PP-332 research compound is used in laboratory settings to investigate metabolic regulation, energy expenditure and cellular bioenergetics.

For a detailed scientific review and study references, see our SLU-PP-332 Research Blog.

Product Information

Product Name: SLU-PP-332
Synonyms: SLU-PP-332 (PPARδ modulator)
Molecular Formula: C24H21F3N2O3S
Molecular Weight: 474.49 g/mol
Class: PPARδ agonist analogue (research compound)
Form: Lyophilized powder (research grade)
Purity: >98% (HPLC tested)
Storage: Store at −20 °C. Protect from light and moisture. Reconstitute using sterile solvents for laboratory use only.

Research Overview

SLU-PP-332 peptide (PPARδ agonist research compound) activates transcriptional programs that increase fatty acid oxidation and mitochondrial biogenesis in experimental models. These effects make it a useful tool for researchers studying fat oxidation, endurance physiology, and metabolic adaptations to prolonged energy demand.

Potential Research Applications

  • Metabolic regulation and lipid metabolism studies
  • Endurance and performance research (mitochondrial adaptation)
  • Fat oxidation and energy-expenditure models
  • Mitochondrial biogenesis and cellular bioenergetics
  • Insulin sensitivity and glucose-utilization research

Scientific Background

PPARδ activation has been linked to improved oxidative metabolism and endurance in preclinical studies. SLU-PP-332 is investigated as a selective PPARδ modulator with the goal of producing beneficial metabolic effects while minimizing off-target activity. Foundational PPARδ literature (e.g., Narkar et al., 2008) informs current experimental use and interpretation of SLU-PP-332 data.

Safety and Handling

SLU-PP-332 is strictly for laboratory research use. It is not approved for human or veterinary use. All handling, reconstitution, and experimental use must be performed by qualified personnel in appropriate laboratory facilities following institutional biosafety protocols. Avoid repeated freeze-thaw cycles and follow disposal regulations for chemical reagents.

Disclaimer

For research use only. Not for human consumption, medical, or veterinary use. Information provided is for educational and scientific reference purposes only.

Explore related compounds in our Research Peptide Shop or read experimental guides in our Peptide Research Blog.

 

 

This product is delivered in 50 x 250mcg in tablet form to make sure it is delivered in the highest quality grade for research.

 

Additional information
Weight250 g
Weigth250mcg
PurityPurity ≥98% (HPLC). COA available on request. Batch-tracked for traceability.
ComplianceRUO only. Not for human or veterinary use. No dosing or administration guidance provided.